Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0169 Transporter Info | ||||
Gene Name | SLC25A11 | ||||
Transporter Name | Mitochondrial 2-oxoglutarate/malate carrier | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC25A11 Modification Sites with Functional and Structural Information | |||||
Sequence |
MAATASAGAG GIDGKPRTSP KSVKFLFGGL AGMGATVFVQ PLDLVKNRMQ LSGEGAKTRE
YKTSFHALTS ILKAEGLRGI YTGLSAGLLR QATYTTTRLG IYTVLFERLT GADGTPPGFL LKAVIGMTAG ATGAFVGTPA EVALIRMTAD GRLPADQRRG YKNVFNALIR ITREEGVLTL WRGCIPTMAR AVVVNAAQLA SYSQSKQFLL DSGYFSDNIL CHFCASMISG LVTTAASMPV DIAKTRIQNM RMIDGKPEYK NGLDVLFKVV RYEGFFSLWK GFTPYYARLG PHTVLTFIFL EQMNKAYKRL FLSG |
||||
PTM type |
X-Acetylation
X-Methylation
X-Oxidation
X-Phosphorylation
X-S-nitrosylation
X-S-sulfenylation
X-Succinylation
X-Sulfoxidation
X-Ubiquitination
X: Amino Acid
|
Acetylation |
|||||
---|---|---|---|---|---|
Alanine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [1] , [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Alanine |
Modified Location |
2 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A11 Alanine 2 has the potential to affect its expression or activity. | ||||
Lysine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
15 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A11 Lysine 15 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A11 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
73 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A11 Lysine 73 has the potential to affect its expression or activity. | ||||
Unclear Residue |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Enhancing the activity of SLC25A11 | [5] | |||
Role of PTM |
On/Off Switch | ||||
Affected Drug/Substrate |
Citrate |
Results for Drug |
Increasing efflux of citrate | ||
Studied Phenotype |
Myeloid leukaemia [ICD11:2B33.1] | ||||
Experimental Material(s) |
Human macrophages; Human myeloid leukaemia (U937) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC25A11 have been reported to enhance its transport activity. | ||||
Methylation |
|||||
Arginine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Arginine |
Modified Location |
78 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Methylation at SLC25A11 Arginine 78 has the potential to affect its expression or activity. | ||||
Oxidation |
|||||
Cystine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
184 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SLC25A11 Cystine 184 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine |
8 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [8] , [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
6 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Serine 6 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A11 | [10] , [11] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
19 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Serine 19 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A11 | [12] , [13] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
52 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Serine 52 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A11 | [14] , [15] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
64 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Serine 64 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLC25A11 | [14] , [15] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
70 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Serine 70 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 6 |
Have the potential to influence SLC25A11 | [16] , [17] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
201 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Serine 201 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 7 |
Have the potential to influence SLC25A11 | [16] , [18] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
203 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Serine 203 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 8 |
Have the potential to influence SLC25A11 | [16] , [17] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
205 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Serine 205 has the potential to affect its expression or activity. | ||||
Threonine |
7 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [9] , [19] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
4 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Threonine 4 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A11 | [10] , [11] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
18 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Threonine 18 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A11 | [14] , [15] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
63 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Threonine 63 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A11 | [14] , [15] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
69 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Threonine 69 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLC25A11 | [18] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
95 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Threonine 95 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 6 |
Have the potential to influence SLC25A11 | [17] , [20] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
103 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Threonine 103 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 7 |
Have the potential to influence SLC25A11 | [17] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
115 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Threonine 115 has the potential to affect its expression or activity. | ||||
Tyrosine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [17] , [21] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
102 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Tyrosine 102 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A11 | [16] , [18] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
202 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A11 Tyrosine 202 has the potential to affect its expression or activity. | ||||
S-nitrosylation |
|||||
Cystine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [22] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
184 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation (-SNO) at SLC25A11 Cystine 184 has the potential to affect its expression or activity. | ||||
S-sulfenylation |
|||||
Cystine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [23] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
184 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-sulfenylation (-SOH) at SLC25A11 Cystine 184 has the potential to affect its expression or activity. | ||||
Succinylation |
|||||
Lysine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [24] , [25] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
57 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Succinylation at SLC25A11 Lysine 57 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A11 | [26] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
256 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Succinylation at SLC25A11 Lysine 256 has the potential to affect its expression or activity. | ||||
Sulfoxidation |
|||||
Methionine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [27] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
33 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Sulfoxidation at SLC25A11 Methionine 33 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A11 | [27] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
127 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Sulfoxidation at SLC25A11 Methionine 127 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A11 | [27] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Methionine |
Modified Location |
303 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Sulfoxidation at SLC25A11 Methionine 303 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Lysine |
4 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A11 | [24] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
57 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A11 Lysine 57 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC25A11 | [24] , [25] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
62 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A11 Lysine 62 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC25A11 | [4] , [24] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
73 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A11 Lysine 73 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC25A11 | [24] , [25] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
162 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A11 Lysine 162 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.